WIDE RANGE OF INTERMEDIATE PRODUCTS FOR THE PHARMACEUTICAL INDUSTRY - BACK TO EUROPE

Pharma

We offer more than just a product, we provide future-oriented solutions with the following intermediate products.

Bioselect^® (high-purity guanidine salts) for biotechnological, diagnostic and pharmaceutical applications.
Cyanamide as an anti-worm agent for human and veterinary medicine.
Dicyandiamide as a synthesis building block for active pharmaceutical ingredients (API's), e.g. for the production of metformin (medication against type II diabetes).
NITRALZ^® (nitriles) for the API production of various medicines for the treatment of e.g. hypertension, heart disease, HIV and cancer.
NIGU^® (Nitroguanidine) as an intermediate in the synthesis of pharmaceuticals and veterinary products
Thiourea as a raw material for the production of various human medicines, e.g. for the treatment of Parkinson's disease.
Creavitalis^® (Creatine Monohydrate) raw material for health applications for vitality and well-being by supporting energy metabolism.

Product
News and Stories

Innovation, sustainability, health & safety play a fundamental role.

We have more than 60 years of experience in the development and manufacture of advanced, high-quality specialty and intermediate products for pharmaceutical applications.

In cooperation with you, we develop tailor-made solutions, such as customized buffer solutions based on guanidine thiocyanate and guanidine hydrochloride. Thanks to our many years of experience and our wide range of technologies, we can offer you a comprehensive service.

Due to our deep market and customer understanding and our stable supply chain, we are able to offer reliable and consistently high quality "Made in Germany" products.

Labor Reagenzglas Pflanzen Pipette Nahaufnahme

Bioselect®

Toll manufacturing

Cyanamide

Dicyandiamide

Nitralz®

Thiourea

Creavitalis®

Pharma Flyer

PDF

Pharma Flyer

889 KB

Act now.

Act together.

The Alzchem Group forms a unique production network. Such an interconnected system conserves resources, saves energy, reduces emissions, transport costs and uses the synergies of an integrated infrastructure.

News and Stories

Alzchem, Personal, Press release

Alzchem Group honoured its employees

On Thursday, 28 November 2024, Alzchem honoured this year's anniversary celebrants and at the same time bid farewell to 33 employees as they retire from active professional life.

Alzchem, Corporate News

Alzchem Group AG: Private placement of Alzchem shares by

Alzchem Group AG has been informed by its shareholders, LIVIA Corporate Development SE und HDI Vier CE GmbH, that the announced private placement of 250,000 shares (representing approximately 2.5% of the share capital) through an accelerated bookbuilding process with institutional investors has been successfully completed.

Alzchem, Corporate News

Alzchem Group AG: LIVIA Corporate Development SE and HDI

LIVIA Corporate Development SE and HDI Vier CE GmbH have informed Alzchem Group AG (ISIN DE000A2YNT30, WKN A2YNT3, Prime Standard) today that they intend to sell a total of up to 250.000 shares of Alzchem Group AG in a private placement.

Alzchem, Event, Fine Chemicals

JEC World 2025

JEC World 2025 – The global leading trade fair for composite materials will once again open its doors in Paris from March 4 to 6, 2025!

Alzchem, Event, Fine Chemicals

European Coatings Show (ECS) 2025 - Nuremberg

European Coatings Show – The leading international trade fair for the coatings and paint industry opens its doors every two years in Nuremberg.